A. Scott Gangloff

Affiliations

  • Chief Technology Officer at Akero Therapeutics Inc. (AKRO), 2024-05-01
  • Svp, Development & Mfrg at Oncobiologics Inc. (ONS), 2016-12-22
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ONS $3.75 37,369 78,573 2016-11-11 Filing